Growth • Blau Farmacêutica
BLAU3
Blau Farmaceutica is a multinational pharmaceutical company, a pioneer in biotechnology in Brazil and a strong institutional player. Its business model focuses on five specialties: oncology, hematology, infectious diseases, anesthesiology, and specialties. The company has a portfolio of highly complex drugs, including biologics, oncology, and antibiotics. Blau is present in several Latin American countries, such as Argentina, Colombia, Peru and Uruguay, and also in the United States. The hospital segment accounts for most of its net revenue.
7,6%
CAGR Revenue 5Y
Revenue Compound Annual Growth Rate in the last 5 years.
-1,9%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
3,1%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
-5,7%
CAGR EPS 5Y
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
5,1%
CAGR OCF 5Y
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!